CooperCompanies Sets Annual Meeting and Stockholder Record Dates
CooperCompanies (NYSE: COO) has announced its annual stockholder meeting scheduled for March 17, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CooperCompanies (NYSE: COO) has announced its annual stockholder meeting scheduled for March 17, 2021. Stockholders on record as of January 21, 2021, will be eligible to vote on important matters, including the election of directors. The company operates through two divisions: CooperVision, focused on vision care and contact lenses, and CooperSurgical, which advances women's health, fertility, and genomics. With over 12,000 employees and sales in more than 100 countries, CooperCompanies maintains a robust global presence.
Positive
- Upcoming annual meeting allows stockholders to vote on key matters.
- Strong operational presence with products sold in over 100 countries.
Negative
- None.
Details
News Market Reaction – COO
The recorded move for COO in the trading session of this news was -0.54%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN RAMON, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced that it will hold its next annual meeting of stockholders on Wednesday, March 17, 2021. Stockholders of record as of the close of business on January 21, 2021 will be eligible to vote on matters presented in the Company's proxy statement, including electing its slate of directors.
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.